Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tigertriever 13 Revascularization Device

K-Number: K220808 · 2022-07-25

Decision Date2022-07-25
Product CodeNRY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Tigertriever 13 Revascularization Device is a medical device manufactured by Rapid Medical , Ltd.. It received FDA 510(k) clearance on 2022-07-25 under approval number K220808. The device is classified under product code NRY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tigertriever 13 Revascularization Device?

Tigertriever 13 Revascularization Device is a medical device that received FDA 510(k) clearance on 2022-07-25. It is manufactured by Rapid Medical , Ltd.. The 510(k) number is K220808.

When was Tigertriever 13 Revascularization Device approved by the FDA?

Tigertriever 13 Revascularization Device received FDA 510(k) clearance on 2022-07-25, under approval number K220808.

What company makes Tigertriever 13 Revascularization Device?

Tigertriever 13 Revascularization Device is manufactured by Rapid Medical , Ltd..

What is the FDA product code for Tigertriever 13 Revascularization Device?

The FDA product code for Tigertriever 13 Revascularization Device is NRY.

Related Clinical Trials

Other Devices by Rapid Medical , Ltd.

Related Devices (Code: NRY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.